INTRODUCTIONAfamelanotide (SCENESSE®) is a synthetic analogue of α‐melanocyte‐stimulating hormone (α-MSH) that induces tanning of the skin. α-MSH is a product of the proopiomelanocortin gene (POMC), which is cleaved into the…

INTRODUCTIONHirsutism is defined as the growth of excessive terminal hair in androgen-dependent sites in females.1 Hirsutism affects 10% to 20% of women,2 having a major impact on their quality of…

INTRODUCTIONVitiligo is an acquired chronic autoimmune cutaneous pigmentary disease of the skin, affecting nearly 1-2% of the population worldwide.1 The disease causes destruction of melanocytes and is characterized by depigmented…

INTRODUCTIONVitiligo is a chronic autoimmune disorder affecting an estimated 0.5–2% of the worldwide population.1 It is characterized by the loss of pigmentation of the skin and overlying hair due to…

INTRODUCTIONA 48-year-old white woman presented with a twelvemonth history of intermittent pruritic pink facial papules and two months of alcohol-induced circumscribed centrofacial flushing. She reported applying tacrolimus 0.03% ointment nightly…

INTRODUCTIONFor many medical students, specialty interest groups provide first exposures and help generate interest in various medical specialties. Specialty interest groups also serve as important resources for gaining information and…

INTRODUCTIONNon-scarring alopecia is the most common presentation regarding hair loss. Evaluation of alopecia often includes laboratory testing for ferritin, thyroid stimulating hormone (TSH), vitamin D, and zinc, as previous studies…

INTRODUCTIONSkin dyspigmentation is a common dermatologic concern, particularly in patients with skin of color.1 Hydroquinone is often used as a first-line therapy for dyschromia, and is approved for treatment of…